{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T20:17:17Z","timestamp":1790108237893,"version":"4.0.1"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["thegreenjournal.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.radonc.2019.03.015","type":"journal-article","created":{"date-parts":[[2019,5,9]],"date-time":"2019-05-09T11:06:57Z","timestamp":1557400017000},"page":"61-70","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":84,"special_numbering":"C","title":["Radiation-induced and neurofibromatosis-associated malignant peripheral nerve sheath tumors (MPNST) have worse outcomes than sporadic MPNST"],"prefix":"10.1016","volume":"137","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4286-5742","authenticated-orcid":false,"given":"Ruoyu","family":"Miao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haotong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5887-6265","authenticated-orcid":false,"given":"Alex","family":"Jacobson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna P.","family":"Lietz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edwin","family":"Choy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin A.","family":"Raskin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph H.","family":"Schwab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikram","family":"Deshpande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. Petur","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0346-3487","authenticated-orcid":false,"given":"Thomas F.","family":"DeLaney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory M.","family":"Cote","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis J.","family":"Hornicek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yen-Lin E.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2019.03.015_b0005","unstructured":"World Health Organization., International Agency for Research on Cancer.: WHO classification of tumours of soft tissue and bone (ed 4th). Lyon, IARC Press, 2013."},{"key":"10.1016\/j.radonc.2019.03.015_b0010","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1245\/s10434-012-2573-2","article-title":"Oncologic outcomes of sporadic, neurofibromatosis-associated, and radiation-induced malignant peripheral nerve sheath tumors","volume":"20","author":"LaFemina","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.radonc.2019.03.015_b0015","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1245\/s10434-011-1978-7","article-title":"Malignant peripheral nerve sheath tumors (MPNST): the Mayo Clinic experience","volume":"19","author":"Stucky","year":"2012","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.radonc.2019.03.015_b0020","doi-asserted-by":"crossref","first-page":"142","DOI":"10.3171\/2012.9.JNS101610","article-title":"Role of resection of malignant peripheral nerve sheath tumors in patients with neurofibromatosis type 1","volume":"118","author":"Dunn","year":"2013","journal-title":"J Neurosurg"},{"key":"10.1016\/j.radonc.2019.03.015_b0025","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1097\/SLA.0b013e3181a77e9a","article-title":"Clinical, pathological, and molecular variables predictive of malignant peripheral nerve sheath tumor outcome","volume":"249","author":"Zou","year":"2009","journal-title":"Ann Surg"},{"key":"10.1016\/j.radonc.2019.03.015_b0030","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1093\/jnci\/djx235","article-title":"Risk of soft-tissue sarcoma among 69 460 five-year survivors of childhood cancer in Europe","volume":"110","author":"Bright","year":"2018","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.radonc.2019.03.015_b0035","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1002\/cncr.22098","article-title":"Malignant peripheral nerve sheath tumors: prognostic factors and survival in a series of patients treated at a single institution","volume":"107","author":"Anghileri","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2019.03.015_b0040","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1002\/1097-0142(19860515)57:10<2006::AID-CNCR2820571022>3.0.CO;2-6","article-title":"Malignant peripheral nerve sheath tumors. A clinicopathologic study of 120 cases","volume":"57","author":"Ducatman","year":"1986","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2019.03.015_b0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.humpath.2017.05.010","article-title":"Histopathologic evaluation of atypical neurofibromatous tumors and their transformation into malignant peripheral nerve sheath tumor in patients with neurofibromatosis 1-a consensus overview","volume":"67","author":"Miettinen","year":"2017","journal-title":"Hum Pathol"},{"key":"10.1016\/j.radonc.2019.03.015_b0050","doi-asserted-by":"crossref","first-page":"7429697","DOI":"10.1155\/2017\/7429697","article-title":"Malignant peripheral nerve sheath tumors state of the science: leveraging clinical and biological insights into effective therapies","volume":"2017","author":"Kim","year":"2017","journal-title":"Sarcoma"},{"key":"10.1016\/j.radonc.2019.03.015_b0055","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1136\/jmg.39.5.311","article-title":"Malignant peripheral nerve sheath tumours in neurofibromatosis 1","volume":"39","author":"Evans","year":"2002","journal-title":"J Med Genet"},{"key":"10.1016\/j.radonc.2019.03.015_b0060","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1002\/pbc.25149","article-title":"Malignant peripheral nerve sheath tumors (MPNST): a SEER analysis of incidence across the age spectrum and therapeutic interventions in the pediatric population","volume":"61","author":"Bates","year":"2014","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.radonc.2019.03.015_b0065","doi-asserted-by":"crossref","first-page":"8422","DOI":"10.1200\/JCO.2005.01.4886","article-title":"Pediatric malignant peripheral nerve sheath tumor: the Italian and German soft tissue sarcoma cooperative group","volume":"23","author":"Carli","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2019.03.015_b0070","first-page":"777","article-title":"Diagnosis, treatment and survival of 65 patients with malignant peripheral nerve sheath tumors","volume":"34","author":"Goertz","year":"2014","journal-title":"Anticancer Res"},{"key":"10.1016\/j.radonc.2019.03.015_b0075","article-title":"Clinicopathological features and prognosis of malignant peripheral nerve sheath tumor: a retrospective study of 159 cases from 1999 to 2016","author":"Yuan","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.radonc.2019.03.015_b0080","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1590\/0004-282x20170052","article-title":"Malignant peripheral nerve sheath tumor with and without neurofibromatosis type 1","volume":"75","author":"Vasconcelos","year":"2017","journal-title":"Arq Neuropsiquiatr"},{"key":"10.1016\/j.radonc.2019.03.015_b0085","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ejca.2015.12.015","article-title":"Management and prognosis of malignant peripheral nerve sheath tumors: The experience of the French Sarcoma Group (GSF-GETO)","volume":"56","author":"Valentin","year":"2016","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.radonc.2019.03.015_b0090","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1093\/neuonc\/nos287","article-title":"Survival meta-analyses for >1800 malignant peripheral nerve sheath tumor patients with and without neurofibromatosis type 1","volume":"15","author":"Kolberg","year":"2013","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.radonc.2019.03.015_b0095","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)\u2013a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform"},{"key":"10.1016\/j.radonc.2019.03.015_b0100","doi-asserted-by":"crossref","DOI":"10.1097\/01.blo.0000131256.82455.c5","article-title":"Survival data for patients with malignant schwannoma","author":"Cashen","year":"2004","journal-title":"Clin Orthop Relat Res:69\u201373"},{"key":"10.1016\/j.radonc.2019.03.015_b0105","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1200\/JCO.2009.25.1728","article-title":"Do radiation-associated soft tissue sarcomas have the same prognosis as sporadic soft tissue sarcomas?","volume":"28","author":"Gladdy","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2019.03.015_b0110","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0360-3016(98)00223-5","article-title":"Malignant peripheral nerve sheath tumor: analysis of treatment outcome","volume":"42","author":"Wong","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2019.03.015_b0115","doi-asserted-by":"crossref","first-page":"324","DOI":"10.3389\/fonc.2014.00324","article-title":"Radiation therapy in management of sporadic and neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors","volume":"4","author":"Kahn","year":"2014","journal-title":"Front Oncol"},{"key":"10.1016\/j.radonc.2019.03.015_b0120","first-page":"1573","article-title":"International consensus statement on malignant peripheral nerve sheath tumors in neurofibromatosis","volume":"62","author":"Ferner","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.radonc.2019.03.015_b0125","doi-asserted-by":"crossref","first-page":"8685638","DOI":"10.1155\/2017\/8685638","article-title":"SARC006: phase II trial of chemotherapy in sporadic and neurofibromatosis type 1 associated chemotherapy-naive malignant peripheral nerve sheath tumors","volume":"2017","author":"Higham","year":"2017","journal-title":"Sarcoma"},{"key":"10.1016\/j.radonc.2019.03.015_b0130","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.ejca.2010.11.013","article-title":"Non-metastatic unresected paediatric non-rhabdomyosarcoma soft tissue sarcomas: results of a pooled analysis from United States and European groups","volume":"47","author":"Ferrari","year":"2011","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.radonc.2019.03.015_b0135","doi-asserted-by":"crossref","first-page":"3133","DOI":"10.1200\/JCO.2008.20.4495","article-title":"Phase II study of sorafenib in patients with metastatic or recurrent sarcomas","volume":"27","author":"Maki","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2019.03.015_b0140","doi-asserted-by":"crossref","first-page":"3148","DOI":"10.1200\/JCO.2008.20.5054","article-title":"Phase II multicenter trial of imatinib in 10 histologic subtypes of sarcoma using a bayesian hierarchical statistical model","volume":"27","author":"Chugh","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2019.03.015_b0145","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1002\/cncr.29858","article-title":"SARC009: Phase 2 study of dasatinib in patients with previously treated, high-grade, advanced sarcoma","volume":"122","author":"Schuetze","year":"2016","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2019.03.015_b0150","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1093\/annonc\/mdw281","article-title":"Phase II study of MLN8237 (Alisertib) in advanced\/metastatic sarcoma","volume":"27","author":"Dickson","year":"2016","journal-title":"Ann Oncol"},{"key":"10.1016\/j.radonc.2019.03.015_b0155","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djx124","article-title":"Neurofibromatosis type 1-associated MPNST state of the science: outlining a research agenda for the future","volume":"109","author":"Reilly","year":"2017","journal-title":"J Natl Cancer Inst"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814019301306?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814019301306?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,19]],"date-time":"2019-08-19T08:11:01Z","timestamp":1566202261000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814019301306"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":31,"alternative-id":["S0167814019301306"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2019.03.015","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Radiation-induced and neurofibromatosis-associated malignant peripheral nerve sheath tumors (MPNST) have worse outcomes than sporadic MPNST","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2019.03.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}